or Try an Advanced Search...

    Technical Analysis for ANIP - ANI Pharmaceuticals, Inc.

    Grade Last Price % Change Price Change
    D 65.36 0.63% 0.41
    ANIP closed up 0.63 percent on Friday, April 26, 2024, on 42 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. It ran into resistance at its 50 day moving average.
    Earnings due: May 6
    *** please verify all earnings dates ***
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Flat Flat
    Historical ANIP trend table...
    Date Alert Name Type % Chg
    50 DMA Resistance Bearish 0.00%
    NR7 Range Contraction 0.00%
    NR7-2 Range Contraction 0.00%
    Fell Below 50 DMA Bearish 0.63%
    NR7 Range Contraction 0.63%
    Gapped Down Weakness 0.63%
    50 DMA Support Bullish -0.11%
    Up 3 Days in a Row Strength -1.18%
    MACD Bearish Centerline Cross Bearish -0.40%
    Spinning Top Other -0.40%
    Older End-of-Day Signals for ANIP ...

       Recent Intraday Alerts

    Alert Time
    Rose Above 50 DMA about 14 hours ago
    Possible NR7 about 14 hours ago
    Up 1% about 15 hours ago
    Rose Above Previous Day's High about 16 hours ago
    50 DMA Resistance about 16 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    ANIP Chart by TradingView
    Basic chart:

    Profile

    ANI Pharmaceuticals, Inc. Description

    ANI Pharmaceuticals, Inc. develops, manufactures, and markets prescription and over-the-counter pharmaceuticals. It offers liquid, powder, oral solid dose, and cough/cold products; and antacids, laxatives, and other stomach remedies. The company also provides hydrocortisone retention enema, esterified estrogen and methyltestosterone, fluvoxamine maleate tablets, hydrocortisone rectal suspension, metoclopramide oral solution, opium tincture, and metoclopramide tablets. In addition, ANI Pharmaceuticals offers contract manufacturing services for other pharmaceutical companies. It offers its products through wholesalers, smaller regional distributors and chains, and pharmacy and retail outlets in the United States. ANI Pharmaceuticals, Inc. was formerly known as ASHCO. The company was founded in 2001 and is based in Baudette, Minnesota. It has manufacturing facilities in Gulfport, Mississippi; and Baudette, Minnesota. ANI Pharmaceuticals, Inc. is a former subsidiary of Bactolac Pharmaceutical Inc.

    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Pharmaceutical Acid Retail Outlets Pharmacology Suspension Manufacturing Facilities Contract Manufacturing Chloroarenes Contract Manufacturing Services Cough Estrogen Antiemetics Testosterone Antacid Laxatives Enema Metoclopramide Offers Contract Manufacturing Services Prolactin Releasers

    Is ANIP a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 26 Bristol-Myers Q1 Loss Narrower Than Expected, Sales Beat
    Apr 18 ANI Pharmaceuticals to Discuss First Quarter 2024 Financial Results on May 10, 2024, at 8:30 a.m. ET
    Apr 18 Sage (SAGE) Down 20% on Parkinson's Study Missing Primary Goal
    Apr 17 GSK Announces FDA Acceptance of New Meningococcal Jab BLA
    Apr 16 Aptevo (APVO) Stock Plummets 79% in a Week: Here's Why
    Apr 16 Marinus (MRNS) Down 83% on Lead Drug Falling Short in Seizure Study
    Apr 15 Enlivex (ENLV) Stock Plummets 51% in a Week: Here's Why
    Apr 15 Why ANI (ANIP) is Poised to Beat Earnings Estimates Again
    Apr 12 ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) is favoured by institutional owners who hold 64% of the company
    Apr 10 ANI Pharmaceuticals (ANIP) Stock Moves -0.13%: What You Should Know
    See more ANIP news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 70.81
    52 Week Low 37.4
    Average Volume 160,816
    200-Day Moving Average 58.75
    50-Day Moving Average 65.56
    20-Day Moving Average 66.45
    10-Day Moving Average 65.49
    Average True Range 1.39
    RSI (14) 45.95
    ADX 19.1
    +DI 18.35
    -DI 22.62
    Chandelier Exit (Long, 3 ATRs) 66.15
    Chandelier Exit (Short, 3 ATRs) 68.36
    Upper Bollinger Bands 68.58
    Lower Bollinger Band 64.32
    Percent B (%b) 0.25
    BandWidth 6.41
    MACD Line -0.21
    MACD Signal Line 0.10
    MACD Histogram -0.3159
    Fundamentals Value
    Market Cap 1.34 Billion
    Num Shares 20.4 Million
    EPS 0.54
    Price-to-Earnings (P/E) Ratio 121.04
    Price-to-Sales 2.57
    Price-to-Book 2.68
    PEG Ratio 1.06
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 66.74
    Resistance 3 (R3) 66.67 66.13 66.51
    Resistance 2 (R2) 66.13 65.78 66.17 66.43
    Resistance 1 (R1) 65.75 65.56 65.94 65.82 66.36
    Pivot Point 65.21 65.21 65.31 65.25 65.21
    Support 1 (S1) 64.83 64.86 65.02 64.90 64.36
    Support 2 (S2) 64.29 64.64 64.33 64.29
    Support 3 (S3) 63.91 64.29 64.21
    Support 4 (S4) 63.98